Search the Newsreel

Cosmopolitan International Sets Board Meeting to Approve Interim Results

Cosmos Machinery Sets August Board Meeting to Review Interim Results and Dividend

Cosmo First Standalone June 2026 Net Sales at Rs 1,058.63 crore, up 40.98% Y-o-Y

Price to earnings forward of Cosmos Health Inc – DUS:V67A

This article provides financial data for Cosmos Health Inc (DUS:V67A) on the Dusseldorf Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It presents a data table with period values and changes, noting that the market is currently closed with no trades. The content …

Cosmo Metals Confirms Broad Gold Mineralisation at Kanowna Project

Cosmos Health Inc (COSM) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cosmos Health Inc (COSM), noting that no earnings forecast score is currently available, but the Pharmaceuticals industry average is 7.86. Analysts have set an average price target of $3.00 for COSM, representing a significant upside. Key financial …

Cosmos Exploration (ASX:C1X) Shares Rise as EAU Lithium Merger Expands the Bolivia Strategy

Cosmo First posts 46% revenue growth, 26% EBITDA rise in Q1FY27

Cosmo First makes Q1FY27 earnings call audio available online

Cosmo First consolidated net profit rises 25.38% in the June 2026 quarter

ASX Stocks Surge Today: Wellnex Life, Falcon Metals and Cosmos Exploration on Investor’s Radar

Cosmo First Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Cosmo First reports 25% PAT rise to ₹53.75 crore in Q1FY27

Cosmo First Reports Q1 Consolidated Net Profit of ₹53.75 Cr vs ₹42.9 Cr YoY

Cosmo First Ltd Share: வருவாய் **46%** உயர்வு! முதலீட்டாளர்களுக்கு காத்திருக்கும் லாபம்!

Cosmo First Limited Approves Cash Dividend for the Year 2026

Cosmo Metals Limited Revenue Breakdown – ASX:CMO

Cosmos Health (NASDAQ: COSM) CEO swaps $70K debt for 349,825 shares

Grigorios Siokas, CEO and Director of Cosmos Health Inc. (NASDAQ: COSM), acquired 349,825 shares of common stock at $0.2001 per share through a debt exchange agreement on July 30, 2026. This transaction converted $70,000 of debt owed to him by the company into equity. …

Cosmo N.V.: Fundamentalanalyse und Finanzratings | A2AJ68 | NL0011832936

Form 4 Cosmos Health Inc. For: 30 July By Investing.com

This article reports on a Form 4 filing for Cosmos Health Inc. (COSM) related to July 30th activities. It indicates that the company's stock experienced a 7.75% increase. The content primarily serves as a brief announcement for the financial filing.

Cosmos Health Inc. (COSM) CFO swaps $60,000 debt for company stock

Cosmos Health Inc. CFO Georgios Terzis acquired 328,407 shares of company common stock at $0.1827 per share. These shares were issued as part of a debt-for-equity exchange totaling $60,000, settling a debt the company owed to Mr. Terzis. Following this transaction, his direct holdings …

Cosmos Exploration Ltd (ASX: C1X): Is This Penny Stock Worth Watching?

Cosmos Exploration Plans Name Change to EAU Lithium Ahead of 2026 Meeting

Cosmo First Limited Revenue Breakdown – NSE:COSMOFIRST

Cosmos Health Advances Its Technology-Driven Transformation

Cosmos Health Inc. is developing an AI-enabled subscription platform for its consumer health products, marking a significant step in its technology-driven transformation. The platform will cater to both B2C and B2B channels, offering personalized recommendations based on customer health goals and supporting employee wellness …

NOOR Collagen Repeat Rate Above 60% as Cosmos Health Develops AI Platform

Cosmos Health is actively developing an AI-enabled digital subscription platform for its consumer health products, targeting both B2C and B2B channels. The initiative builds on the success of its U.S. NOOR Collagen subscription model, which boasts an early repeat purchase rate of over 60%. …

Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Cosmos Health Inc (COSM), focusing on its support and resistance levels, various technical indicators, and moving averages. The stock is currently trading within a range, with a price momentum score of 6.11. The analysis provides signals from …

Cosmopolitan International Holdings Limited Revenue Breakdown – HKEX:120

Galaxy Cosmos Mezz Plc Revenue Breakdown – ATHEX:GCMEZZ

Cosmos Health Inc (COSM) Institutional Confidence

Cosmos Health Inc (COSM) has an institutional shareholding score of 3.00, placing it 92nd out of 155 in the Pharmaceuticals industry. The institutional shareholding proportion is 2.84%, a 67.39% decrease quarter-over-quarter. James Simons is the largest institutional shareholder, holding 0.78% of outstanding shares.

Cosmos Health Inc (COSM) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Cosmos Health Inc (COSM) stock, focusing on its dividend history and stock splits. It states that the company has not distributed any dividends over the past five years. The article also details multiple stock merger events that occurred …

Cosmos Health Inc (COSM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Cosmos Health Inc (COSM), focusing on its regional revenue contributions. As of the updated report on April 6, the company's revenue is predominantly generated from Greece, accounting for 95.77% of total revenue. Other contributing regions include the …

Cosmos Health Inc (COSM) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Cosmos Health Inc (COSM), outlining its major individual and institutional holders. It provides a breakdown of shareholder types, institutional holdings over several quarters, and recent shareholder activity with changes in their stake. Key shareholders include Grigorios Siokas, …